Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC

Conditions:   Premenopausal Breast Cancer;   Metastatic Breast Cancer;   ER Positive Breast Cancer Interventions:   Drug: Goserelin;   Drug: Fulvestrant;   Drug: Capivasertib;   Drug: Durvalumab Sponsor:   National Taiwan University Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials